# ondansetron

NDC: 16729-298
Generic name: ondansetron
Labeler / Manufacturer: Accord Healthcare, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20161020

FDA application: ANDA206846

## Active ingredients

- ONDANSETRON: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16729-298"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16729-298
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35e0d160-813f-41d7-a382-d2cab6485d9c